subject: Global Data: Meningitis Preventive Vaccines - Pipeline Assessment and Market Forecasts [print this page] Global Data: Meningitis Preventive Vaccines - Pipeline Assessment and Market Forecasts
GlobalData, the industry analysis specialist, has released its new report, "Meningitis Preventive Vaccines Pipeline Assessment and Market Forecasts to 2017". The report is an essential source of information and analysis on the global Meningitis Preventive Vaccines market. The report identifies the key trends shaping and driving the global Meningitis Preventive Vaccines market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Meningitis Preventive Vaccines sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. GlobalData has estimated the global Meningitis Preventive Vaccines market to be valued at $1.8 billion in 2009. It is expected to increase to $4.5 billion with a Compound Annual Growth Rate (CAGR) of (12%)by 2017. The market structure is projected to change in the near future following the entrance of new blockbuster products till 2017. Menveo Iis expected to come in the market by 2011 and Novartis menB vaccine by 2014 in US. There is a low unmet need in the current Meningitis Preventive Vaccines market in terms of both safety and efficacy profile
* The report provides information on the key drivers and challenges of the Alzheimer's disease market. Its scope includes:
* Annualized global Meningitis Preventive Vaccines market revenues data from 2001 to 2009, forecast for eight years to 2017.
* Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends. Pipeline candidates fall under major vaccine classes such as of conjugate vaccine, recombinant vaccine and antigen vaccine.
* Analysis of the current and future competition in the global Meningitis Preventive Vaccines market. Key market players covered are Sanofi Pasteur, Merck & Co., Novartis, GSK.
* Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
* Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Meningitis Preventive Vaccines market.
GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage including oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries.
Visit our Report Store
http://www.globaldata.com/reportstore/
welcome to Insurances.net (https://www.insurances.net)
